Roanoke-based Chorda Pharma moves toward product release with grant Gene Marrano June 27, 2022 1 minute read Chorda Pharma, a local pharmaceutical company looking to bring its first product, Capsadyn – an over the counter medication for chronic pain to market next year – has received an important grant from the Commonwealth Commercialization Fund. Share: Post navigation Previous: Congressman Bob Good pushes Life at Conception ActNext: Late on returning library books? That’s no longer a problem Related Stories 19 years later, the Excel Center Adult High School helps her graduate with a hard-earned diploma Gene Marrano July 21, 2026 Excel Center will welcome more students; holding job fairs as well Gene Marrano July 21, 2026 Roanoke councilman accuses colleague of racist remark Web Staff July 18, 2026
